BELTAVAC polymerized grass mix
Sponsors
Probelte Pharma S.L.
Conditions
Allergic rhinoconjunctivitis caused due to exposure to pollen grassesallergic rhinoconjunctivitis caused due to exposure to pollen grasses
Phase 2
Randomized, double-blind, placebo-controlled clinical trial to evaluate the optimal dose of Beltavac® with polymerized extract of grass pollen mixture in patients with allergic rhinoconjunctivitis associated or not with asthma.
WithdrawnCTIS2023-510033-28-00
Target: 150Updated: 2024-06-14
Randomized, double-blind, placebo-controlled clinical trial to evaluate the optimal dose of Beltavac® with polymerized extract of grass pollen mixture in patients with allergic rhinoconjunctivitis associated or not with asthma.
WithdrawnCTIS2025-520581-22-00
Target: 120Updated: 2025-06-16